First patient dosed in the Phase 1 trial of IMC-P115C, marking a significant milestone in the development of Immunocore's novel immunotherapy. IMC-P115C is designed to improve patient convenience by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback